These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17984215)

  • 1. Long-term effect of cardiac resynchronisation in patients reporting mild symptoms of heart failure: a report from the CARE-HF study.
    Cleland JG; Freemantle N; Daubert JC; Toff WD; Leisch F; Tavazzi L
    Heart; 2008 Mar; 94(3):278-83. PubMed ID: 17984215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure?
    Turley AJ; Raja SG; Salhiyyah K; Nagarajan K
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
    Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
    Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
    Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
    Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
    Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
    Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac resynchronisation therapy: evidence based benefits and patient selection.
    Albouaini K; Egred M; Rao A; Alahmar A; Wright DJ
    Eur J Intern Med; 2008 May; 19(3):165-72. PubMed ID: 18395159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
    Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
    Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of biventricular pacing in heart failure patients with narrow QRS, NYHA class II and right ventricular pacing.
    Ng K; Kedia N; Martin D; Tchou P; Natale A; Wilkoff B; Starling R; Grimm RA
    Pacing Clin Electrophysiol; 2007 Feb; 30(2):193-8. PubMed ID: 17338715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization with sequential biventricular pacing for the treatment of moderate-to-severe heart failure.
    León AR; Abraham WT; Brozena S; Daubert JP; Fisher WG; Gurley JC; Liang CS; Wong G;
    J Am Coll Cardiol; 2005 Dec; 46(12):2298-304. PubMed ID: 16360062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure--the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study.
    Linde C; Gold M; Abraham WT; Daubert JC;
    Am Heart J; 2006 Feb; 151(2):288-94. PubMed ID: 16442890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long term results of cardiac resynchronisation therapy for patients with severe heart failure].
    Bulava A; Lukl J; Hutyra M; Marek D
    Vnitr Lek; 2007 Nov; 53(11):1153-63. PubMed ID: 18277624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
    De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
    J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac resynchronization therapy in heart failure patients: an update.
    Jeevanantham V; Daubert JP; Zareba W
    Cardiol J; 2009; 16(3):197-209. PubMed ID: 19437393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac resynchronization therapy in mild heart failure.
    Linde C
    Europace; 2009 Nov; 11 Suppl 5():v72-6. PubMed ID: 19861394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
    Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
    Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional behavior of patients with conventional pacemakers undergoing cardiac resynchronization.
    Silva RT; Martinelli Filho M; Lima CE; Martins DG; Nishióka SA; Pedrosa AA; Crevelari ES; Costa R; Sosa EA; Ramires JA
    Arq Bras Cardiol; 2008 Feb; 90(2):138-43. PubMed ID: 18392387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial fibrillation in recipients of cardiac resynchronization therapy device: 1-year results of the randomized MASCOT trial.
    Padeletti L; Muto C; Maounis T; Schuchert A; Bongiorni MG; Frank R; Vesterlund T; Brachmann J; Vicentini A; Jauvert G; Tadeo G; Gras D; Lisi F; Dello Russo A; Rey JL; Boulogne E; Ricciardi G;
    Am Heart J; 2008 Sep; 156(3):520-6. PubMed ID: 18760135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longer-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac REsynchronization-Heart Failure (CARE-HF) trial extension phase].
    Cleland JG; Daubert JC; Erdmann E; Freemantle N; Gras D; Kappenberger L; Tavazzi L
    Eur Heart J; 2006 Aug; 27(16):1928-32. PubMed ID: 16782715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatment.
    Inage T; Yoshida T; Hiraki T; Ohe M; Takeuchi T; Nagamoto Y; Fukuda Y; Gondo T; Imaizumi T
    Europace; 2008 Mar; 10(3):379-83. PubMed ID: 18227354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.